info icon

Pneumonia derived septicemia

SEPTICHE_PNEUMONIA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

1283

6. Filter based on genotype QC (FinnGen only)

1283

Control definitions (FinnGen only)

Control exclude
ASTHMA_INFECTIONS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1283 582 701
Unadjusted period prevalence (%) 0.26 0.20 0.31
Median age at first event (years) 57.72 52.75 61.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1124
Matched controls
11237
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
412.2
323.0
382
14
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
+∞
323.0
927
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
10.5
268.9
692
1489
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
10.4
144.8
310
397
0382A
ICD-9 Finland
Septicaemia, Pneumococcal septicaemia
+∞
101.6
96
*
J01MA14
ATC
moxifloxacin; systemic
6.6
75.1
210
377
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
75.0
322
942
A41.9
ICD-10 Finland
Sepsis, unspecified
10.4
69.5
142
154
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
67.5
621
3248
J01MA12
ATC
levofloxacin; systemic
3.6
61.2
331
1156
A41.3
ICD-10 Finland
Sepsis due to Haemophilus influenzae
+∞
53.6
51
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.7
51.5
256
821
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
50.9
213
586
J45.9
ICD-10 Finland
Asthma, unspecified
4.0
50.0
223
649
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.1
49.4
213
601
R03BB04
ATC
tiotropium bromide; inhalant
4.6
44.1
165
403
R50.9
ICD-10 Finland
Fever, unspecified
3.3
43.9
254
907
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
8.0
43.3
102
139
03820
ICD-8 Finland
Septicaemia, Pneumococcal
+∞
43.0
41
*
H02AB06
ATC
prednisolone; systemic
2.3
39.4
541
3191
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
35.5
160
462
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
35.2
301
1363
J01FF01
ATC
clindamycin; systemic
2.5
33.9
345
1714
J86.9
ICD-10 Finland
Pyothorax without fistula
17.0
32.7
52
32
R03AC02
ATC
salbutamol; inhalant
2.1
32.6
580
3734
G00.1
ICD-10 Finland
Pneumococcal meningitis
+∞
32.4
31
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
32.4
234
952
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
32.1
158
489
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
31.6
587
3832
J45.1
ICD-10 Finland
Nonallergic asthma
5.2
30.6
99
205
C03CA01
ATC
furosemide; systemic
2.3
30.5
375
2028
R81
ICPC
Pneumonia
6.5
29.3
78
127
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
15.4
28.0
46
31
ZXD05
NOMESCO Finland
Urgent procedure
2.1
26.7
382
2184
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.3
26.6
84
169
C90.0
ICD-10 Finland
Multiple myeloma
14.7
26.3
44
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
25.8
203
859
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
25.6
164
612
WX872
NOMESCO Finland
Intensive care
4.3
24.8
97
244
J01CA04
ATC
amoxicillin; systemic
2.2
24.8
903
7362
WX892
NOMESCO Finland
Monitored bed care
3.3
24.5
133
441
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.4
24.5
76
150
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
24.4
98
253
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.0
24.3
101
269
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
24.1
188
790
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
18.6
23.6
36
20
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
22.3
204
933
ZX120
NOMESCO Finland
Intravenous
2.9
22.1
141
522
R06.0
ICD-10 Finland
Dyspnoea
2.2
21.9
275
1463
153
Kela drug reimbursment
Lenalidomid
29.7
21.9
29
10
J46
ICD-10 Finland
Status asthmaticus
12.2
21.6
39
33
A46
ICD-10 Finland
Erysipelas
2.5
21.1
184
818
L04AX04
ATC
lenalidomide; oral
28.7
21.0
28
10
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.0
20.1
82
215
A41.8
ICD-10 Finland
Other specified sepsis
7.2
20.1
49
71
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
19.9
85
232
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.0
19.9
55
95
WW200
NOMESCO Finland
Immunization
5.8
19.4
55
98
R03BA05
ATC
fluticasone; inhalant
2.3
19.3
195
932
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.4
19.3
99
314
R03AC12
ATC
salmeterol; inhalant
5.4
19.3
59
115
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
19.3
103
337
R4110
NOMESCO Finland
Physiotherapy
2.0
19.3
306
1779
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
19.2
107
359
H02AB07
ATC
prednisone; oral
2.5
19.1
164
721
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
18.9
326
1956
R03DA04
ATC
theophylline; systemic, rectal
4.2
18.9
74
187
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
18.3
206
1035
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
37.3
17.6
22
6
J45
ICD-10 Finland
Asthma
3.2
17.2
95
318
R03DC03
ATC
montelukast; oral
2.4
16.9
151
677
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
16.9
98
340
A02BC02
ATC
pantoprazole; systemic
1.7
16.9
652
5014
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
16.8
185
917
I50.0
ICD-10 Finland
Congestive heart failure
2.9
16.6
105
385
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
16.5
450
3114
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
23.4
16.5
23
10
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.8
16.4
70
192
J01DB01
ATC
cefalexin; oral
1.8
16.4
873
7371
R02
ICPC
Shortness of breath/dyspnoea
2.5
15.9
136
595
J96.1
ICD-10 Finland
Chronic respiratory failure
6.3
15.9
42
69
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
15.7
53
116
Z3226
NOMESCO Finland
Physiotherapist
2.0
15.7
218
1191
4810A
ICD-9 Finland
Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]
26.7
15.6
21
8
TK800
NOMESCO Finland
Hemodialysis
5.5
15.5
46
87
N05BA01
ATC
diazepam; systemic, rectal
2.3
15.2
154
731
C07AB07
ATC
bisoprolol; oral
1.7
15.2
485
3494
ZXE00
NOMESCO Finland
One hour or less
1.7
15.0
419
2900
J45.8
ICD-10 Finland
Mixed asthma
7.2
14.7
35
50
Z3231
NOMESCO Finland
Registered nurse
1.8
14.6
310
1967
R96
ICPC
Asthma
2.9
14.6
92
336
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
14.3
71
221
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
14.3
66
194
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
10.6
14.3
27
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
14.1
295
1860
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
13.9
181
958
H02AB04
ATC
methylprednisolone; systemic
2.2
13.7
155
775
S97
ICPC
Chronic ulcer skin
3.0
13.4
77
265
SPAT1262
SPAT
Handing over of treatment supplies
2.0
13.4
202
1134
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
13.4
72
238
N02AX02
ATC
tramadol; systemic, rectal
1.6
13.2
422
3002
R03BA02
ATC
budesonide; inhalant
2.1
13.2
172
909
R95
ICPC
Chron obstructive pulmonary disease
5.2
13.1
40
79
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.5
13.1
61
181
TK810
NOMESCO Finland
Hemofiltration
11.1
13.0
24
22
120
Kela drug reimbursment
Hypogammaglobulinaemia
28.7
13.0
17
6
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
12.9
84
315
R05
ICPC
Cough
1.8
12.9
236
1418
N05CF01
ATC
zopiclone; oral
1.7
12.9
323
2145
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.9
12.8
41
86
R03BA01
ATC
beclometasone; inhalant
2.3
12.7
126
590
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
12.7
157
815
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.7
877
7598
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.4
12.6
37
70
WX882
NOMESCO Finland
High dependency care
3.8
12.6
53
145
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.0
12.6
50
130
J01FA06
ATC
roxithromycin; oral
1.6
12.5
385
2705
J15.4
ICD-10 Finland
Pneumonia due to other streptococci
131.4
12.5
13
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
12.3
116
530
M04AA01
ATC
allopurinol; systemic
2.0
12.1
157
830
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
12.1
105
462
6BA02
NOMESCO Finland
NA
27.0
12.1
16
6
C03DA01
ATC
spironolactone; oral
2.2
12.1
127
615
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
12.1
48
125
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.0
12.1
48
125
J96.0
ICD-10 Finland
Acute respiratory failure
7.3
12.0
28
39
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
12.0
716
5910
A03
ICPC
Fever
1.9
12.0
186
1053
R03AC13
ATC
formoterol; inhalant
3.6
12.0
53
151
Z2446
NOMESCO Finland
Social worker
2.5
12.0
95
398
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
12.0
182
1024
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.9
288
1883
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.3
11.9
43
102
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
11.9
193
1110
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
11.9
203
1187
WX722
NOMESCO Finland
PEEP
3.0
11.8
67
230
A07AA02
ATC
nystatin; oral
2.8
11.7
77
290
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.4
11.7
41
95
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.9
11.7
37
77
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
30.4
11.7
15
5
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
65.6
11.6
13
*
Z2221
NOMESCO Finland
Medical doctor
1.7
11.6
295
1957
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
11.5
83
331
0384A
ICD-9 Finland
Septicaemia due to other gram-negative organisms[SEPTICHAEMIA HAEMOPHILUS INFLUENZAE]
+∞
11.5
11
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.7
11.5
38
83
127
Kela drug reimbursment
Transplant complication
5.3
11.4
34
66
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
11.4
50
142
L04AA06
ATC
mycophenolic acid; systemic
4.9
11.4
36
75
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
11.2
146
771
WW500
NOMESCO Finland
Blood transfusion
3.1
11.2
61
204
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.1
11.1
60
200
N02AA05
ATC
oxycodone; systemic
2.0
11.0
158
867
J01DA01
ATC
[U] cefalexin; systemic
1.5
11.0
622
5021
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.8
10.9
70
261
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
10.8
153
836
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
10.8
246
1576
AA1AA
NOMESCO Finland
Head X-ray examination
9.7
10.8
21
22
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
28.3
10.7
14
5
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
21.7
10.7
15
7
SPAT1255
SPAT
Intravenous administration of medicine
2.6
10.7
81
332
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.3
10.6
53
167
ZX108
NOMESCO Finland
Inhalation
8.1
10.6
23
29
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
10.5
100
463
A12AA04
ATC
calcium carbonate; oral
5.5
10.5
30
56
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
10.4
118
589
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
+∞
10.4
10
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.1
10.4
39
97
B01AA03
ATC
warfarin; systemic
1.7
10.4
224
1410
L03AA02
ATC
filgrastim; parenteral
3.9
10.4
42
112
WX725
NOMESCO Finland
Noninvasive ventilation
2.9
10.4
62
222
B01AB05
ATC
enoxaparin; parenteral
1.6
10.2
290
1970
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
10.2
64
235
SPAT1254
SPAT
Administration of medicine
1.8
10.2
176
1031
JN4BD
NOMESCO Finland
Extensive body CT
2.1
10.2
124
638
A02BC01
ATC
omeprazole; systemic
1.6
10.1
274
1837
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.3
10.1
36
85
ZX112
NOMESCO Finland
Subcutaneous
4.6
10.1
34
76
J20
ICD-10 Finland
Acute bronchitis
2.3
10.0
98
457
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
10.0
74
301
R06AE07
ATC
cetirizine; oral
1.5
10.0
412
3074
AA1AD
NOMESCO Finland
CT of head and brain
1.7
9.8
240
1565
H02AB09
ATC
hydrocortisone; systemic
3.7
9.8
41
113
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.6
9.8
24
37
A28
ICPC
Limited function/disability NOS
1.9
9.7
157
900
A06AD11
ATC
lactulose; oral
1.9
9.7
158
909
Z72.0
ICD-10 Finland
Tobacco use
4.1
9.6
36
90
L04AA01
ATC
[U] ciclosporin; systemic
5.5
9.5
27
50
GBB00
NOMESCO Finland
Tracheostomy
5.8
9.5
26
46
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
9.5
240
1577
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
9.5
357
2597
L04AD01
ATC
ciclosporin; systemic
4.5
9.5
32
72
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
9.5
86
389
A10AE04
ATC
insulin glargine; parenteral
2.1
9.5
107
534
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
9.3
273
1867
L01AA01
ATC
cyclophosphamide; systemic
10.8
9.3
17
16
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
9.2
296
2071
B03XA02
ATC
darbepoetin alfa; parenteral
4.9
9.2
29
61
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.8
9.1
20
26
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
9.1
334
2413
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.9
9.1
54
193
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
11.6
9.1
16
14
R03AK11
ATC
formoterol and fluticasone; inhalant
4.8
9.1
29
62
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
10.1
9.0
17
17
J01AA02
ATC
doxycycline; systemic
1.5
9.0
740
6341
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
9.0
58
219
J47
ICD-10 Finland
Bronchiectasis
5.5
8.9
25
46
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.4
8.8
76
335
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
8.7
72
311
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
8.7
101
510
A04AA01
ATC
ondansetron; systemic, rectal
2.4
8.7
74
323
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
6.2
8.6
22
36
R03BB01
ATC
ipratropium bromide; inhalant
3.1
8.6
45
148
B34.9
ICD-10 Finland
Viral infection, unspecified
3.5
8.6
38
110
N07BB01
ATC
disulfiram; oral
2.8
8.6
54
199
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.5
8.6
29
66
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
27.7
8.5
11
*
49300
ICD-8 Finland
Asthma, bronchiale
6.0
8.5
22
37
N03AX16
ATC
pregabalin; oral
1.6
8.5
215
1411
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
8.4
73
324
WX730
NOMESCO Finland
Conventional respirator
4.3
8.3
29
68
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.7
8.3
27
59
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
8.6
8.3
17
20
N18.0
ICD-10 Finland
End-stage renal disease
5.6
8.3
23
42
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.3
218
1444
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
9.5
8.3
16
17
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.7
8.2
22
39
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.1
423
3278
SPAT1263
SPAT
Sampling
1.5
8.1
432
3363
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
8.1
35
100
WW300
NOMESCO Finland
Transfer of autologic stem cells
11.8
8.1
14
12
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.8
8.1
32
85
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.0
8.0
16
18
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.6
8.0
34
96
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
8.0
112
609
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
8.0
73
332
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
8.0
190
1226
C01AA05
ATC
digoxin; systemic
2.0
8.0
96
493
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
8.0
64
271
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
5.0
7.9
24
49
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.0
7.9
24
49
J01FA09
ATC
clarithromycin; systemic
1.5
7.8
285
2046
TGC00
NOMESCO Finland
Bronchial lavation
3.6
7.8
33
93
N05AA02
ATC
levomepromazine; systemic
2.7
7.7
51
196
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.7
372
2830
Z94.0
ICD-10 Finland
Kidney transplant status
5.6
7.7
21
38
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
7.7
89
448
WX110
NOMESCO Finland
Local anesthesy
1.4
7.6
685
5871
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
8.1
7.6
16
20
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
25.2
7.6
10
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.9
7.6
15
17
WX704
NOMESCO Finland
Intubation
2.2
7.5
74
348
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
80.6
7.4
8
*
R03AK08
ATC
formoterol and beclometasone; inhalant
3.5
7.4
32
92
A11CC03
ATC
alfacalcidol; systemic
3.4
7.4
33
98
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.4
7.4
33
98
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
7.4
45
166
H02AB02
ATC
dexamethasone; systemic
2.0
7.3
95
501
JN4AD
NOMESCO Finland
Body CT examination
2.1
7.3
81
403
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
7.3
87
445
N03AG01
ATC
valproic acid; systemic, rectal
2.2
7.3
69
320
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
7.3
76
368
393
Kela drug reimbursment
Pomalidomide
+∞
7.3
7
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.5
7.3
24
54
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.8
7.3
44
161
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.3
7.2
25
59
329
Kela drug reimbursment
Lenalidomide
15.9
7.2
11
7
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
5.8
7.2
19
33
V03AE01
ATC
polystyrene sulfonate; oral
4.7
7.2
23
50
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
4.1
7.2
26
64
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
7.1
130
773
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
20.2
7.1
10
5
N05AB03
ATC
perphenazine; systemic, rectal
3.0
7.1
38
129
M10.9
ICD-10 Finland
Gout, unspecified
2.1
7.0
72
347
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
7.0
91
482
N17.8
ICD-10 Finland
Other acute renal failure
5.0
7.0
21
43
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.5
6.9
30
87
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.5
6.9
30
87
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
6.9
63
286
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
6.9
66
308
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
6.9
75
371
L04AX01
ATC
azathioprine; systemic
2.5
6.9
52
217
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.0
6.8
25
63
M05BA04
ATC
alendronic acid; oral
2.1
6.8
75
374
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.8
6.8
27
73
J80
ICD-10 Finland
Adult respiratory distress syndrome
9.4
6.8
13
14
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.8
317
2388
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.8
400
3150
GAC46
NOMESCO Finland
Partial decortication of pleura
16.8
6.7
10
6
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.9
6.7
20
41
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.7
324
2455
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
6.7
360
2786
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
6.7
76
384
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.5
6.6
29
85
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
5.9
6.6
17
29
E000001
ATC
NA
1.6
6.6
200
1369
I95.9
ICD-10 Finland
Hypotension, unspecified
4.4
6.6
22
51
M46.4
ICD-10 Finland
Discitis, unspecified
10.1
6.5
12
12
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.5
6.5
28
81
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
6.9
6.5
15
22
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.1
6.5
19
38
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
6.4
57
255
WW402
NOMESCO Finland
Leucoferesis
70.2
6.4
7
*
1XX32
NOMESCO Finland
NA
70.2
6.4
7
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.4
6.4
14
19
EBA00
NOMESCO Finland
Extraction of tooth
1.4
6.4
322
2458
ZXD35
NOMESCO Finland
Usual procedure
2.7
6.4
39
145
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.4
6.4
21
48
K08.3
ICD-10 Finland
Retained dental root
2.1
6.4
71
354
R03AC18
ATC
indacaterol; inhalant
8.2
6.3
13
16
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.2
6.3
18
35
R03AC03
ATC
terbutaline; inhalant
1.8
6.3
111
654
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
6.3
42
164
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
11.1
6.3
11
10
A40.0
ICD-10 Finland
Sepsis due to streptococcus, group A
9.3
6.3
12
13
I50
ICD-10 Finland
Heart failure
2.8
6.3
37
134
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
6.3
6
*
L04AX06
ATC
pomalidomide; oral
+∞
6.3
6
*
R11
ICD-10 Finland
Nausea and vomiting
1.9
6.2
85
460
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
26.8
6.2
8
*
N05CD07
ATC
temazepam; oral
1.7
6.2
125
769
A07AA09
ATC
vancomycin; oral
5.1
6.2
18
36
B03XA01
ATC
erythropoietin; parenteral
5.1
6.2
18
36
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.2
200
1389
A02BC05
ATC
esomeprazole; systemic
1.4
6.1
347
2700
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
8.6
6.1
12
14
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.0
6.0
22
56
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
6.0
285
2145

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
673
2704
4.13
138.13
6.7
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
424
1594
3.48
88.94
2.6
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
260
742
4.14
81.44
5.1
2.7
g/l
12.2
10.7
2.47
238
676
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
315
1112
3.43
71.29
2.4
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
313
1111
3.40
70.11
2.3
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
633
3382
2.72
66.79
9.1
6.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
72
73
10.39
63.60
1.4
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
200
601
3.76
57.11
2.6
1.8
g/l
1.3
1.4
0.25
180
549
(3027801) Oxygen [Partial pressure] in Arterial blood
276
1055
3.06
53.32
9.4
8.3
kpa
10.2
12.4
12.75
254
1008
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
276
1055
3.06
53.32
9.4
8.3
kpa
5.1
5.1
0.16
254
1006
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
102
189
5.78
53.21
1.5
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
102
189
5.78
53.21
1.5
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
273
1052
3.03
51.88
9.5
8.3
mmol/l
1.7
1.0
1.51
218
814
(3019069) Monocytes/100 leukocytes in Blood
739
4695
2.35
48.27
10.5
6.2
%
8.2
8.7
3.48
702
4407
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
277
1120
2.88
47.92
4.4
4.2
u/l
248.1
256.1
0.26
264
1052
(3006504) Eosinophils/100 leukocytes in Blood
735
4671
2.34
47.80
10.1
6.0
%
2.5
2.9
3.36
697
4363
(3002030) Lymphocytes/100 leukocytes in Blood
752
4836
2.34
47.42
10.1
6.0
%
25.5
28.2
6.34
714
4525
(3022096) Basophils/100 leukocytes in Blood
718
4532
2.33
47.25
10.1
6.0
%
0.6
0.7
2.48
676
4243
(3018010) Neutrophils/100 leukocytes in Blood
741
4757
2.32
46.61
9.8
5.8
%
59.7
56.7
6.45
701
4465
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
123
303
4.38
45.89
3.0
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
315
1401
2.65
45.04
2.8
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
307
1368
2.64
43.58
10.2
6.6
mmol/l
1.1
1.1
1.27
287
1268
(3011412) CD3 cells [#/volume] in Blood
63
87
7.56
43.52
2.5
2.8
e9/l
1.4
1.1
1.00
37
41
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
54
62
9.05
43.38
2.3
3.1
%
9.1
11.8
0.75
26
37
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
82
154
5.62
42.06
1.8
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
761
5113
2.20
40.54
10.3
6.1
e9/l
0.2
0.2
0.31
674
4484
(3016502) Oxygen saturation in Arterial blood
236
953
2.81
40.40
10.0
8.8
%
93.0
95.6
4.72
223
919
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
100
233
4.57
39.95
2.1
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
49
57
8.90
38.94
2.3
3.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
56
77
7.56
38.80
1.4
1.4
g/l
2.3
2.8
0.85
37
56
(3024139) IgG subclass 3 [Mass/volume] in Serum
56
77
7.56
38.80
1.4
1.4
g/l
0.4
0.4
0.01
37
57
(3027135) IgG subclass 1 [Mass/volume] in Serum
56
77
7.56
38.80
1.4
1.4
g/l
10.0
6.6
1.57
34
57
(3019198) Lymphocytes [#/volume] in Blood
753
5094
2.16
38.68
9.9
5.8
e9/l
2.0
1.9
0.33
673
4476
(3001604) Monocytes [#/volume] in Blood
734
4933
2.14
38.14
9.9
5.7
e9/l
0.6
0.6
6.91
645
4251
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
97
229
4.50
38.10
2.1
1.6
—
—
—
0
0
(4062490)
56
79
7.37
37.93
1.4
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
734
4950
2.13
37.58
10.0
5.8
e9/l
0.0
0.0
0.71
644
4274
(3020779) Urea [Moles/volume] in Serum or Plasma
223
908
2.76
37.39
12.8
8.5
mmol/l
11.5
9.7
2.53
213
865
(3013650) Neutrophils [#/volume] in Blood by Automated count
813
5729
2.14
36.71
15.0
8.9
e9/l
4.7
4.1
8.43
719
4993
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
741
5051
2.11
36.43
9.0
6.3
umol/l
10.8
12.0
1.73
715
4774
(3020630) Protein [Mass/volume] in Serum or Plasma
202
791
2.84
36.42
5.6
2.7
g/l
67.6
66.2
1.00
177
716
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
72
138
5.47
36.09
1.9
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
66
118
5.84
35.62
1.8
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
67
122
5.74
35.47
1.8
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
234
1006
2.62
35.08
7.1
4.8
kpa
5.9
5.8
0.68
228
972
(3002032) Base excess in Venous blood by calculation
232
995
2.63
34.94
7.1
4.8
mmol/l
1.8
1.8
0.02
199
774
(3012095) Magnesium [Moles/volume] in Serum or Plasma
314
1559
2.34
34.37
4.8
3.9
mmol/l
0.8
0.8
1.50
293
1457
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
115
332
3.71
34.31
3.1
3.3
u/ml
0.3
0.4
1.05
70
191
(3037756) Immunofixation for Serum or Plasma
86
201
4.51
34.17
2.1
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
282
1343
2.41
33.89
3.5
2.7
%
19.3
23.1
5.30
240
1154
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
127
396
3.45
33.71
2.3
1.8
ug/l
3.3
2.1
0.61
114
349
(46235355) HIV 1 and 2 tests - Meaningful Use set
369
1989
2.20
32.97
1.9
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
255
1179
2.45
32.61
2.6
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
292
1435
2.34
32.54
3.4
2.6
g/l
2.2
2.3
2.76
273
1325
(3027945) Reticulocytes/100 erythrocytes in Blood
253
1172
2.44
32.18
3.8
2.8
%
1.9
1.7
2.40
223
1047
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
658
4426
2.00
31.99
11.9
6.4
mmol/l
1.2
1.2
2.56
614
4007
(3019060) Gas panel - Arterial blood
162
603
2.93
31.88
7.3
5.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
66
132
5.22
31.54
1.8
1.9
g/l
0.5
0.8
1.30
48
107
(3002173) Hemoglobin [Mass/volume] in Arterial blood
205
871
2.61
31.26
10.8
9.0
g/l
116.6
122.0
3.16
194
839
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
137
472
3.13
30.85
9.9
11.0
mmol/l
24.6
24.3
0.44
126
437
(3023419) Bacteria identified in Sputum by Culture
56
99
5.87
30.56
3.9
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
176
706
2.73
30.03
2.1
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
696
4853
1.95
29.64
13.8
7.0
mmol/l
1.2
1.2
2.78
594
4101
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
132
456
3.11
29.56
2.1
2.0
g/l
1.6
1.5
0.48
114
400
(3004588) Protein electrophoresis panel - Serum or Plasma
163
634
2.80
29.49
5.9
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
84
217
4.07
29.27
6.9
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
299
1549
2.21
29.02
3.4
2.6
umol/l
10.6
13.2
8.88
279
1424
(3014111) Lactate [Moles/volume] in Serum or Plasma
198
862
2.53
28.57
8.6
7.9
mmol/l
1.6
1.4
0.66
188
818
(3032080) INR in Blood by Coagulation assay
600
4020
1.93
28.39
13.2
9.7
inr
1.3
1.3
0.29
190
1165
(3024561) Albumin [Mass/volume] in Serum or Plasma
618
4202
1.91
27.77
8.6
5.1
g/l
32.8
35.5
19.20
576
3908
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
45
71
6.53
27.47
2.6
2.9
e9/l
0.2
0.2
0.21
33
59
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
75
6.32
27.21
2.5
2.8
e6/l
700.3
582.0
0.33
33
60
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
98
300
3.45
26.68
7.1
3.2
mg/l
93.4
32.5
0.92
77
244
(3034860) Kappa light chains.free [Mass/volume] in Serum
97
298
3.44
26.26
7.1
3.3
mg/l
73.1
77.8
0.07
77
240
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
95
292
3.43
25.69
7.1
3.2
ratio
6.2
1.9
—
5
26
(3000991) Gas panel - Venous blood
194
884
2.41
25.19
11.1
9.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
193
880
2.40
25.02
3.9
2.7
e9/l
73.5
68.0
0.96
146
683
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
131
498
2.82
24.62
12.7
12.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
783
5880
1.85
24.46
8.8
4.9
mmol/l
6.9
6.7
1.78
742
5467
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
75
205
3.82
24.14
7.1
6.8
iu/ml
533.1
486.1
0.05
17
33
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
146
593
2.65
24.13
2.0
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
63
152
4.31
24.01
3.4
3.7
%
2.1
1.3
0.41
55
129
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
139
564
2.64
22.99
6.7
5.7
mmol/l
24.2
23.9
0.53
132
521
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
93
303
3.23
22.90
5.1
2.8
g/l
4.1
1.0
2.39
72
264
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
349
3.06
22.52
5.7
2.6
g/l
7.5
7.4
0.25
67
265
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
349
3.06
22.52
5.7
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
349
3.06
22.52
5.7
2.6
g/l
4.3
3.7
1.05
62
258
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
329
3.11
22.32
5.5
2.6
g/l
3.1
3.2
0.24
62
261
(3026008) Bacteria identified in Urine by Culture
451
2926
1.83
22.16
3.6
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
436
2800
1.84
22.14
4.2
3.2
e6/l
0.7
0.5
0.88
342
2128
(40758558) Short blood count panel - Blood
397
2480
1.87
21.99
10.2
6.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
270
3.30
21.80
1.9
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
481
3197
1.81
21.72
4.4
3.4
u/l
50.5
33.7
0.65
450
3038
(3008152) Bicarbonate [Moles/volume] in Arterial blood
141
593
2.55
21.64
10.7
7.6
mmol/l
24.7
24.5
0.19
127
548
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
64
169
3.93
21.62
2.1
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
136
563
2.58
21.57
1.5
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
413
2627
1.84
21.51
2.7
2.2
mg/l
3.2
2.9
1.08
358
2230
(3002582) Erythrocytes [#/volume] in Urine
466
3076
1.81
21.48
4.3
3.3
e6/l
45.4
92.8
1.17
367
2384
(44790049)
53
123
4.45
21.23
1.8
1.6
—
—
—
0
0
(44806118)
53
123
4.45
21.23
1.8
1.6
—
—
—
0
0
(44790047)
53
123
4.45
21.23
1.8
1.6
—
—
—
0
0
(44790048)
53
123
4.45
21.23
1.8
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
313
1828
1.94
21.18
5.1
3.6
ng/l
331.2
397.0
0.23
258
1423
(3017181) Myelocytes/100 leukocytes in Blood
171
793
2.33
21.17
4.9
4.2
%
0.8
0.8
0.01
82
241
(3024354) Oxygen [Partial pressure] in Venous blood
182
868
2.28
21.10
5.3
4.2
kpa
4.8
4.6
0.41
175
839
(3023199) Leukocytes [#/volume] in Pleural fluid
51
117
4.50
20.72
1.3
1.4
e6/l
1667.0
1683.0
0.01
35
84
(3003434) Protein [Mass/volume] in Pleural fluid
54
130
4.29
20.64
1.3
1.5
g/l
34.5
31.6
0.76
43
114
(3026782) Osmolality of Urine
336
2026
1.89
20.57
3.4
2.8
mosm/kgh2o
518.6
568.4
4.06
298
1736
(3018418) pH of Serum or Plasma
431
2810
1.80
20.50
6.9
4.0
ph
7.4
7.4
0.71
88
539
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
48
106
4.67
20.44
2.1
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
23
23
10.16
20.31
2.1
2.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
418
2709
1.81
20.23
4.1
3.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
326
3.00
20.21
5.3
2.6
g/l
14.2
10.2
2.41
66
278
(3021589) Normoblasts [#/volume] in Blood
618
4484
1.73
20.12
14.5
9.5
e9/l
0.0
0.0
0.55
512
3666
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
55
138
4.12
19.92
2.1
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
392
2.80
19.80
7.1
5.9
%
0.9
0.9
0.11
95
369
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
45
97
4.77
19.72
2.2
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
389
2492
1.81
19.43
6.8
4.1
%
85.0
87.7
1.30
377
2440
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
156
722
2.32
19.34
7.9
4.2
mmol/l
2.1
1.6
0.71
117
529
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
250
3.21
19.06
1.3
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
104
400
2.74
19.05
6.8
5.8
%
1.8
1.6
1.22
94
376
(3045788) Cell count panel - Pleural fluid
43
92
4.80
19.02
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
155
721
2.31
18.98
4.6
4.0
%
1.0
0.5
0.68
61
182
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
189
954
2.15
18.96
3.2
2.5
g/l
0.2
0.2
1.85
167
887
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
83
284
3.06
18.81
3.2
1.4
g/l
0.2
0.2
0.42
76
270
(3018095) Leukocytes [#/volume] in Urine
513
3591
1.71
18.60
4.8
3.7
e6/l
33.7
125.2
3.27
380
2547
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
65
195
3.46
18.24
1.5
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
84
295
2.98
18.19
3.1
1.4
g/l
1.1
1.2
1.22
79
278
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
164
795
2.22
18.17
4.7
2.9
ng/l
337.1
212.0
1.91
148
732
(3031040) Bacteria [#/volume] in Urine by Automated count
827
6623
1.70
17.68
6.0
4.3
e6/l
53.7
2350.5
—
8
102
(3009343) pH of Capillary blood
156
749
2.23
17.68
8.0
4.1
ph
7.4
7.4
0.76
26
92
(3021440) Promyelocytes/100 leukocytes in Blood
156
750
2.23
17.62
5.0
4.3
%
0.1
0.1
0.50
76
221
(3000060) B lymphocytes [#/volume] in Blood
25
34
7.48
17.42
2.2
3.6
e6/l
300.0
312.3
—
9
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
38
79
4.93
17.38
3.9
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
220
1212
1.98
17.33
9.8
7.4
mmol/l
103.6
104.4
1.42
213
1186
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
35
68
5.26
17.28
2.6
3.0
%
44.1
40.5
0.26
13
19
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
913
7537
1.73
17.18
12.4
7.2
u/l
90.8
80.7
4.58
873
7065
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
156
758
2.20
17.16
8.0
4.1
kpa
5.1
5.2
0.63
146
709
(3039000) Anion gap in Blood
66
208
3.29
17.15
9.3
8.6
mmol/l
11.9
11.4
0.55
57
188
(3018572) Chloride [Moles/volume] in Blood
66
208
3.29
17.15
9.3
8.6
mmol/l
104.0
105.6
1.29
57
188
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
16
11.40
17.12
2.3
2.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
262
1553
1.86
16.50
2.3
2.4
s
30.5
29.7
1.24
254
1506
(3007164) IgA [Mass/volume] in Serum or Plasma
323
2043
1.78
16.42
2.1
1.5
g/l
2.4
2.4
0.04
224
1216
(3028308) Erythrocytes [#/volume] in Pleural fluid
43
104
4.24
16.36
1.3
1.4
e6/l
122442.6
127821.5
0.02
26
64
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
49
131
3.85
16.30
6.6
6.4
mg/l
11.3
11.3
0.01
44
118
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
270
1643
1.81
15.54
1.8
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
56
5.46
15.47
2.3
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
296
1856
1.77
15.38
2.1
1.7
nmol/l
1150.9
1174.7
0.14
229
1394
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
60
191
3.25
15.35
1.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
67
229
3.03
15.22
6.0
3.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
117
535
2.31
14.84
1.6
1.2
u/ml
150.3
243.5
0.90
107
490
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
77
289
2.77
14.78
4.2
2.6
g/l
36.9
37.5
0.35
60
247
(3012501) Base excess in Blood by calculation
65
224
3.00
14.57
6.7
4.4
mmol/l
2.5
2.8
0.30
44
142
(3008757) Leukocyte morphology finding [Identifier] in Blood
44
119
3.79
14.42
3.5
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
264
1629
1.78
14.39
3.7
3.0
e6/l
3.9
2.0
1.37
146
918
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
42
110
3.91
14.39
2.1
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
402
2783
1.65
14.35
3.8
3.1
ng/l
2619.8
1617.2
2.64
341
2381
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
429
3024
1.63
14.23
3.2
2.6
u/l
53.5
58.0
1.85
405
2787
(3023183) Ammonium ion [Moles/volume] in Plasma
68
244
2.89
14.19
2.6
3.3
umol/l
35.7
35.7
0.01
62
203
(3047181) Lactate [Moles/volume] in Blood
77
296
2.70
14.12
9.8
7.3
mmol/l
1.3
1.3
0.31
66
255
(3025159) Blasts/100 leukocytes in Blood
142
717
2.10
14.09
5.1
4.3
%
0.0
0.6
0.67
65
195
(3000850) Epithelial cells [#/volume] in Urine
324
2134
1.69
13.95
3.4
2.6
e6/l
7.4
5.5
1.18
289
1876
(3001122) Ferritin [Mass/volume] in Serum or Plasma
577
4383
1.58
13.88
4.0
2.8
ug/l
189.4
132.1
2.49
534
4029
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
26
47
5.63
13.87
2.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
26
47
5.63
13.87
2.5
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
200
1148
1.88
13.75
3.8
3.1
umol/l
8.4
8.8
0.08
166
985
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
80
4.34
13.42
2.4
2.3
e6/l
704.5
732.5
0.06
14
33
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
269
1701
1.74
13.38
3.7
2.8
e6/l
2.1
1.0
1.77
154
986
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
71
270
2.73
13.30
4.7
2.7
g/l
0.1
0.0
0.49
63
248
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
49
5.40
13.27
3.7
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
195
1123
1.87
13.25
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
207
1218
1.83
13.12
1.9
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
67
252
2.75
12.82
4.5
2.8
g/l
0.0
0.0
0.00
59
232
(3042631) Mycobacterium sp identified in Specimen
43
126
3.50
12.56
3.6
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
207
1234
1.81
12.54
1.5
1.3
titre
641.5
486.3
0.50
54
246
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
67
255
2.72
12.54
4.5
2.7
g/l
0.0
0.0
0.49
59
233
(3010421) pH of Blood
69
267
2.67
12.51
6.6
4.1
ph
7.4
7.4
0.07
64
221
(21494890) Protein electrophoresis panel - 24 hour Urine
35
90
3.97
12.32
4.1
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
38
104
3.73
12.27
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
90
402
2.33
12.05
2.7
1.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
20
32
6.33
12.03
4.4
4.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
75
310
2.51
11.90
2.8
3.7
g/l
3.9
3.6
0.67
69
291
(3017817) Protein [Mass] in Urine collected for unspecified duration
30
73
4.18
11.37
4.1
2.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
65
257
2.61
11.31
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
69
4.28
11.31
2.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
70
288
2.51
11.23
4.4
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
71
295
2.49
11.16
1.6
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
58
218
2.74
11.14
3.3
2.3
g/l
124.5
130.7
1.12
45
172
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
175
1029
1.81
11.03
4.4
3.3
—
—
—
0
0
(3017704) Immunofixation for Urine
27
62
4.43
11.01
2.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
75
4.07
10.98
1.6
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
197
2.82
10.97
4.5
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1109
10046
1.77
10.96
31.9
13.6
mg/l
38.7
24.8
20.04
995
7866
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
35
98
3.64
10.95
1.1
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
110
563
2.04
10.50
9.2
4.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
30
78
3.91
10.42
2.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
30
78
3.91
10.42
2.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
30
78
3.91
10.42
2.0
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
817
6934
1.49
10.34
5.9
4.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
133
740
1.89
9.98
7.1
4.5
ng/l
115.8
87.8
1.64
118
646
(40768806) Pleura Pathology biopsy report
36
110
3.34
9.90
1.3
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
13
9.31
9.88
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
79
364
2.25
9.86
2.6
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
48
175
2.81
9.79
1.6
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
132
3.10
9.72
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
159
2.90
9.72
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
147
852
1.82
9.69
2.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
137
780
1.85
9.56
1.4
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
44
156
2.89
9.45
1.5
1.6
mmol/l
59.2
67.7
0.64
32
133
(3013707) Erythrocyte sedimentation rate by Westergren method
841
7243
1.47
9.39
5.9
3.8
mm/h
21.6
12.0
24.66
779
6634
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
34
5.36
9.17
1.2
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
188
2.67
9.09
4.2
3.4
%
57.7
57.1
0.09
49
188
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
65
288
2.32
8.91
3.4
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
345
2529
1.50
8.84
4.8
2.9
umol/l
378.5
7185.3
9.72
309
2191
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
24
60
4.06
8.81
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
43
157
2.80
8.77
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
429
3292
1.46
8.69
4.7
3.3
mmol/l
2.3
2.3
2.27
378
2875
(40767503) Oxygen content in Capillary blood by calculation
53
217
2.50
8.64
4.1
2.4
%
15.4
16.2
0.80
33
117
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
294
2095
1.52
8.60
2.0
1.9
mg/l
1.8
1.3
1.35
237
1589
(3000475) Leukocytes [#/volume] in Synovial fluid
55
230
2.45
8.58
1.6
1.8
e6/l
38689.8
16991.0
0.91
43
164
(3042111) Morphology [Interpretation] in Bone marrow Narrative
43
159
2.76
8.57
1.7
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
472
3698
1.44
8.52
5.3
3.6
ng/l
45.2
58.2
0.49
350
2573
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
53
219
2.48
8.48
1.7
1.6
u/ml
107.9
107.5
—
9
35
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
502
3987
1.43
8.37
2.3
2.0
pmol/l
93.2
94.7
0.34
304
2089
(3035880) pH of Pleural fluid
23
59
3.95
8.17
1.4
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
318
2325
1.49
8.17
1.8
1.5
nmol/l
19.7
20.0
0.14
281
1968
(3020191) Ethanol [Moles/volume] in Serum or Plasma
28
83
3.43
8.10
1.8
1.5
promille
1.3
1.2
0.14
23
66
(3052592) Norovirus Ag [Presence] in Stool
13
20
6.56
8.07
1.4
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
5
22.17
8.02
1.5
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
147
900
1.72
8.01
3.3
2.3
u/l
33.0
87.1
0.50
120
761
(3044640) Blood type and Crossmatch panel - Blood
408
3145
1.44
7.92
3.7
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
296
2146
1.49
7.89
6.9
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
378
2879
1.44
7.81
2.6
2.1
u/l
269.2
256.5
0.06
346
2705
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
489
3908
1.41
7.70
2.9
2.3
nmol/l
75.5
75.7
0.06
444
3483
(3009508) Creatinine [Moles/volume] in Urine
405
3133
1.43
7.66
4.3
3.3
mmol/l
6.5
7.9
8.29
338
2627
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
53
230
2.36
7.65
1.6
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
569
4670
1.39
7.64
6.0
4.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
18
6.72
7.61
1.6
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
330
2.12
7.52
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
367
2797
1.44
7.51
4.6
3.3
mg/l
1500.4
288.8
2.06
256
1839
(3022217) INR in Platelet poor plasma by Coagulation assay
191
1271
1.59
7.50
24.8
25.9
inr
1.3
1.3
0.02
15
173
(3017354) Segmented neutrophils/100 leukocytes in Blood
30
99
3.08
7.34
3.4
3.4
%
58.2
53.2
0.45
24
75
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
46
4.18
7.29
2.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
46
4.18
7.29
2.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
46
4.18
7.29
2.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
46
4.18
7.29
2.3
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
144
901
1.67
7.23
2.9
2.1
nmol/l
392.5
373.5
0.14
130
824
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
751
6489
1.38
7.20
4.5
3.2
u/l
76.2
48.0
5.47
702
6060
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
38
4.52
7.19
2.6
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
185
1236
1.58
7.13
2.4
1.7
%
1.6
1.5
1.41
154
1081
(3002385) Erythrocyte distribution width [Ratio]
941
8453
1.42
7.10
34.7
16.8
%
14.2
13.6
20.31
918
8270
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
38
147
2.63
6.99
1.6
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
54
247
2.24
6.93
2.8
2.0
mg/l
11.4
12.1
0.26
48
224
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
43
178
2.46
6.90
1.3
1.2
u/ml
1.0
7.2
—
9
15
(3028271) Lactate [Moles/volume] in Capillary blood
40
160
2.55
6.89
3.1
1.7
mmol/l
1.6
1.7
0.05
40
155
(3024928) Oxygen saturation in Venous blood
48
210
2.34
6.83
4.9
5.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
27
89
3.08
6.64
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
377
2943
1.40
6.60
5.0
4.1
mg/mmol
28.3
9.7
2.17
263
1915
(3030905) Polymorphonuclear cells [#/volume] in Blood
43
182
2.41
6.59
4.1
3.0
e9/l
4.7
4.2
0.55
43
182
(3028433) Virus identified in Specimen by Culture
17
41
4.19
6.56
1.6
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
37
4.37
6.50
2.4
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
37
4.37
6.50
2.4
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
50
228
2.24
6.48
1.3
1.2
u/ml
1.6
2.5
—
9
24
(3047189) Immunofixation for 24 hour Urine
18
46
3.95
6.45
2.4
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
95
550
1.79
6.31
1.4
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
52
244
2.18
6.30
1.3
1.2
u/ml
28.1
16.3
—
9
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
50
231
2.21
6.29
1.3
1.2
u/ml
9.6
14.3
0.23
16
35
(4010399)
101
597
1.75
6.25
1.5
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
26
5.04
6.23
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
71
377
1.94
6.18
2.3
3.1
s
21.3
21.7
0.33
63
339
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
110
2.77
6.14
1.5
1.6
%
67.4
62.9
0.26
20
74
(3000012) Reticulocyte production index
18
48
3.79
6.10
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
109
664
1.70
6.06
3.4
2.6
e9/l
4.6
4.1
0.79
87
522
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
46
209
2.25
6.03
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
45
203
2.26
6.00
2.4
3.1
nmol/l
0.8
0.9
0.51
35
156
(3019977) pH of Arterial blood
19
54
3.56
5.89
3.2
3.6
ph
7.4
7.4
—
6
19
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
52
252
2.11
5.83
1.7
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
21
5.27
5.53
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
393
1.85
5.48
2.4
2.4
u/l
8499.1
3573.1
0.48
30
170
(3033705) Calcium.ionized [Moles/volume] in Venous blood
32
129
2.52
5.48
4.5
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
34
4.15
5.36
3.1
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
60
318
1.93
5.29
9.7
7.7
mg/l
1.6
1.5
0.21
55
295
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
49
3.50
5.18
1.6
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
54
3.37
5.17
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
54
3.37
5.17
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
36
3.92
4.99
4.9
3.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
29
117
2.51
4.98
1.3
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
119
782
1.58
4.93
5.4
3.9
mmol/l
1.2
1.2
0.01
107
671
(3051611) Lipemic interference index of Serum or Plasma
26
100
2.63
4.91
3.6
3.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
84
2.77
4.79
1.4
1.2
u/l
127.2
60.5
0.61
18
56
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
57
3.19
4.77
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
16
47
3.43
4.75
1.6
1.2
u/l
35.4
19.5
0.57
16
41
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
102
2.58
4.73
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
566
4874
1.29
4.71
4.8
3.5
estimate
0.0
0.0
0.00
126
946
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
99
2.56
4.48
1.7
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
16
49
3.29
4.47
1.6
1.2
u/l
322.6
76.6
0.53
16
44
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
162
2.19
4.46
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
568
4917
1.28
4.45
4.7
3.5
estimate
0.0
0.0
0.80
122
924
(3051651) Icteric interference index of Serum or Plasma
19
65
2.95
4.45
3.9
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
562
4860
1.28
4.44
6.5
4.8
estimate
0.0
0.0
0.50
129
961
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
302
2406
1.33
4.41
3.5
2.3
—
—
—
0
0
(3020891) Body temperature
65
376
1.77
4.40
8.2
4.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
999
9300
1.34
4.39
31.8
14.8
%
38.0
40.0
8.68
674
6696
(3024263) Appearance of Synovial fluid
16
50
3.23
4.34
1.3
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
26
107
2.46
4.32
1.7
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
263
2060
1.35
4.29
2.0
1.7
pmol/l
51163240.8
24722159.7
0.21
215
1707
(3004616) Nuclear Ab [Presence] in Serum
26
108
2.44
4.24
1.3
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
36
3.64
4.21
2.8
2.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
160
2.16
4.18
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
66
390
1.73
4.16
2.2
1.9
u/l
38.1
38.3
0.02
59
348
(40761536) Microorganisms panel - Urine sediment
128
888
1.49
4.16
5.1
3.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
104
2.43
4.07
5.6
2.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
63
2.88
4.07
2.9
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
100
2.43
3.90
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
100
2.43
3.90
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
11
7.31
3.86
1.3
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
16
54
2.99
3.85
2.2
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
149
1081
1.43
3.85
1.6
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
15
49
3.09
3.81
1.1
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
27
121
2.26
3.75
3.6
7.0
mmol/l
6.9
6.8
0.06
27
100
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
45
245
1.87
3.74
1.4
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
56
2.88
3.63
4.9
7.4
u/ml
33.0
71.7
—
5
17
(3010375) cycloSPORINE [Mass/volume] in Blood
15
51
2.96
3.58
43.7
32.2
ug/l
113.8
141.7
0.69
15
44
(1761868) Lipid panel - Serum or Plasma
277
3371
0.77
3.53
2.9
2.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
57
2.83
3.53
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
67
418
1.64
3.50
4.0
3.7
g/l
0.4
0.3
0.82
37
196
(3024471) HLA-A [Type]
13
41
3.19
3.50
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
52
2.91
3.47
2.0
1.2
u/ml
3.0
0.1
—
5
22
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
113
2.24
3.43
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
117
833
1.45
3.37
2.9
2.3
ug/l
5.8
7.3
0.75
96
728
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
83
2.43
3.31
1.4
1.4
%
24.4
27.1
0.12
14
55
(3015171) Extractable nuclear Ab [Units/volume] in Serum
55
332
1.69
3.27
1.5
1.2
u/ml
0.5
0.8
—
5
16
(40768446) Kidney Pathology biopsy report
13
43
3.04
3.25
2.9
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
42
235
1.81
3.24
1.4
1.3
u/ml
227.3
232.1
0.05
21
132
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
49
2.88
3.19
1.2
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
15
55
2.75
3.16
3.1
1.9
mmol/l
8.9
9.8
—
10
46
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
306
1.69
3.12
1.6
1.5
iu/ml
0.1
0.1
0.03
11
59
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
118
2.14
3.11
2.4
2.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
52
831
0.61
3.10
1.5
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
54
330
1.66
3.09
4.2
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
112
2.16
3.07
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
63
401
1.60
3.07
1.3
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
16
62
2.60
3.05
1.8
2.4
min
484.1
508.6
—
9
45
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
12
5.86
3.02
8.3
5.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
100
2.22
3.00
1.5
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
81
2.37
2.99
1.9
2.4
ml
674.6
628.8
—
9
54
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
34
183
1.88
2.98
1.3
1.1
u/ml
62.3
29.0
—
6
12
(3024932) HLA-DR beta [Type]
12
40
3.02
2.97
1.2
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
57
2.65
2.97
1.5
3.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
281
1.70
2.93
1.4
1.4
ug/g
303.0
282.3
0.23
24
160
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
30
3.35
2.91
1.3
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
9
6.69
2.87
1.3
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
57
874
0.64
2.86
1.2
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
59
377
1.59
2.85
3.0
3.5
u/ml
108.0
3899.3
0.80
44
320
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
31
165
1.90
2.82
3.5
2.6
u/ml
145.4
30.8
0.58
31
156
(3019550) Sodium [Moles/volume] in Serum or Plasma
1072
10239
1.29
2.82
34.7
16.0
mmol/l
138.8
139.6
18.99
1048
9954
(3023103) Potassium [Moles/volume] in Serum or Plasma
1074
10263
1.29
2.80
34.8
16.1
mmol/l
4.0
4.0
0.67
1045
9960
(3014891) Appearance of Pleural fluid
8
18
4.47
2.79
1.4
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
31
3.24
2.77
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
575
0.56
2.77
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
713
6540
1.20
2.73
3.6
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
317
2689
1.24
2.70
4.7
3.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
10
6.02
2.70
1.0
1.7
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
6
10
6.02
2.70
1.0
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
35
197
1.80
2.70
1.7
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
19
4.23
2.68
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
84
591
1.45
2.62
1.8
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
55
2.56
2.62
1.2
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
33
3.05
2.53
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
26
3.48
2.48
1.2
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
26
3.48
2.48
2.0
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
16
4.39
2.47
1.4
4.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
76
2.25
2.44
3.6
9.4
%
9.9
11.3
0.58
17
76
(40768443) Skin Pathology biopsy report
59
393
1.53
2.42
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
18
83
2.19
2.41
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
27
3.35
2.39
1.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
64
2.36
2.39
1.7
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
64
2.36
2.39
1.7
2.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
40
2.77
2.37
1.1
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
8
6.27
2.37
1.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
13
4.63
2.27
5.7
9.8
mmol/l
11.3
7.6
—
6
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
15
66
2.29
2.25
18.5
20.3
nmol/l
1477.4
1435.1
0.09
15
66
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
29
3.12
2.22
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
143
1.84
2.20
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
203
1.69
2.19
1.4
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
46
297
1.57
2.19
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
42
266
1.60
2.17
4.9
4.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
69
487
1.44
2.16
4.9
3.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
30
3.01
2.15
3.8
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
30
3.01
2.15
3.8
2.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
908
9525
0.84
2.11
4.4
4.2
mmol/l
1.4
1.4
2.27
843
8732
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
43
2.57
2.10
1.1
1.1
iu/ml
384.9
197.3
0.33
11
43
(3009871) Measles virus Ab [Titer] in Serum
8
26
3.09
2.01
1.8
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
26
3.09
2.01
2.4
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
55
378
1.48
1.99
3.3
2.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
21
3.35
1.96
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
51
2.37
1.95
2.5
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
215
1811
1.22
1.95
3.6
3.0
mmol/l
2.5
2.4
2.38
175
1593
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
27
2.97
1.93
1.1
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
16
3.76
1.93
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
45
300
1.52
1.89
1.3
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
228
1.60
1.89
1.9
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
95
726
1.33
1.89
2.0
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
380
0.57
1.87
1.1
1.7
mg/l
4.5
3.0
0.44
16
270
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
49
334
1.49
1.86
1.6
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
919
9598
0.85
1.86
4.5
4.3
mmol/l
4.5
4.6
2.05
861
8847
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
124
986
1.29
1.85
3.5
4.2
ug/l
16.2
24.7
0.31
103
819
(3022493) Free Hemoglobin [Mass/volume] in Plasma
11
46
2.40
1.85
1.7
4.1
mg/l
41.6
67.0
1.69
11
36
(4034850)
16
301
0.53
1.83
18.9
9.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
101
1.89
1.81
1.4
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
215
1.60
1.80
1.9
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
418
3762
1.16
1.79
5.4
3.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
45
305
1.49
1.77
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
182
2157
0.82
1.75
2.5
3.1
ug/l
0.7
0.8
0.93
121
1426
(3022689) Creatine [Moles/volume] in Urine
7
24
2.93
1.72
1.1
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
24
2.93
1.72
8.1
6.1
—
—
—
0
0
(44813793)
13
61
2.14
1.72
1.1
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
1.8
1.4
nmol/l
7.0
4.1
—
5
8
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
89
1.92
1.70
1.1
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
31
2.59
1.66
1.3
1.1
—
—
—
0
0
(4027681)
13
62
2.11
1.66
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
25
2.81
1.65
1.7
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
150
1.68
1.64
1.6
1.2
u/ml
4.6
3.7
—
7
46
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
49
2.26
1.64
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
49
2.26
1.64
1.7
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
14
3.58
1.61
2.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
218
1874
1.20
1.61
1.5
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
32
2.51
1.60
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
258
2255
1.18
1.58
4.3
3.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
231
1.53
1.58
1.5
1.9
e6/l
1786.5
545.5
0.47
28
193
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
231
1.53
1.58
1.5
1.8
e6/l
409.3
43.2
1.02
28
186
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
20
3.01
1.58
1.5
1.1
—
—
—
0
0
(3013512) EKG study
315
2800
1.17
1.57
5.0
3.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
20
114
1.77
1.57
1.8
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
151
1256
1.23
1.56
1.3
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
12
57
2.12
1.55
1.2
1.1
ratio
1.1
1.0
—
5
20
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
64
2.04
1.54
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
64
2.04
1.54
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
64
2.04
1.54
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
177
1502
1.21
1.51
1.3
1.2
iu/ml
51.0
30.8
0.83
60
457
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
21
2.87
1.50
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
93
1166
0.78
1.50
17.5
7.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1083
10516
1.19
1.50
27.7
13.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
79
1.91
1.49
1.5
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
65
2.01
1.49
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
65
2.01
1.49
3.3
2.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
65
2.01
1.49
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
65
2.01
1.49
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
880
9168
0.87
1.48
4.1
3.8
mmol/l
1.4
1.3
2.86
813
8367
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
34
227
1.51
1.47
1.6
1.8
mmol/l
3.6
3.8
0.18
29
212
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
132
1.68
1.46
2.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
132
1.68
1.46
2.2
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
28
2.51
1.45
1.4
2.3
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
7
28
2.51
1.45
10.7
7.9
g/mol
35.7
56.6
—
7
23
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
80
1.89
1.45
1.3
2.6
u/field
1.5
2.1
—
6
27
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
52
2.13
1.44
1.2
1.3
—
47.1
—
0
7
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
16
3.13
1.44
3.2
3.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
133
1.67
1.43
2.2
1.5
—
—
—
0
0
(4094501)
13
239
0.54
1.43
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
145
1215
1.22
1.42
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.1
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
134
1.65
1.39
2.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
134
1.65
1.39
2.2
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
29
2.42
1.39
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
60
2.01
1.38
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
89
1.81
1.37
1.7
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
17
2.95
1.36
1.2
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
17
2.95
1.36
1.2
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
17
2.95
1.36
1.2
1.0
—
—
—
0
0
(4035726)
100
809
1.26
1.35
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
912
9455
0.88
1.33
4.9
4.4
mmol/l
6.1
5.9
3.42
825
8561
(3016879) Cocaine [Presence] in Urine
59
446
1.34
1.33
3.1
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
415
0.67
1.32
1.4
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
129
1.64
1.30
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
251
1.45
1.29
1.8
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
18
2.78
1.28
1.8
6.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
62
475
1.32
1.28
3.0
2.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
44
2.05
1.27
1.2
1.2
u/l
145.9
526.8
—
9
39
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
241
0.58
1.25
2.1
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
70
1.87
1.24
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
70
549
1.29
1.23
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
711
6750
1.12
1.23
4.8
3.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
63
1.91
1.23
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
63
1.91
1.23
1.8
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
62
479
1.31
1.22
3.0
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
56
1.97
1.22
1.7
1.2
nmol/l
153.9
136.3
0.28
11
56
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
49
648
0.75
1.21
1.2
1.2
iu/ml
189.6
129.2
0.32
16
245
(3029075) Extractable nuclear Ab panel - Serum
8
37
2.17
1.21
1.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
132
1.60
1.20
2.2
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
269
2990
0.87
1.20
3.6
4.3
%
22.7
21.3
0.63
120
1456
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
946
9763
0.88
1.19
4.9
4.7
mmol/l
2.6
2.7
3.29
872
8942
(3028300) Cannabinoids [Presence] in Urine
62
481
1.30
1.19
3.0
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
149
1.55
1.17
2.8
3.0
umol/l
6.9
9.9
0.61
17
113
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
257
1.41
1.16
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
19
118
1.62
1.15
1.5
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
150
1.54
1.15
1.6
1.2
u/ml
6.9
5.4
0.22
12
64
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
30
2.34
1.12
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
251
1.41
1.11
2.7
2.5
ug/min
178.0
88.9
0.63
21
152
(3032057) Clostridioides difficile [Presence] in Stool
5
21
2.39
1.09
1.8
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
242
0.62
1.07
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
526
1.27
1.06
3.3
3.3
pmol/l
4.6
4.6
0.04
61
464
(3000034) Microalbumin [Mass/volume] in Urine
14
82
1.72
1.05
2.7
3.5
mg/l
32.3
14.5
—
8
64
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
90
1.67
1.04
1.1
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
2.8
2.1
umol/l
19.7
17.1
—
5
22
(3029396) Erythrocyte agglutination [Presence] in Blood
5
22
2.28
1.03
2.2
3.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
101
1198
0.83
1.03
4.9
4.3
%
33.4
31.8
0.74
81
798
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
98
1.64
1.03
1.3
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
163
1.48
1.02
5.8
3.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
68
1.77
1.00
1.4
1.2
—
—
—
0
0
(4015189)
5
23
2.18
0.98
2.6
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
60
478
1.27
0.98
2.6
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
547
0.76
0.98
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
292
2671
1.12
0.95
5.5
3.7
estimate
0.0
0.0
0.04
116
919
(3028707) Methadone [Presence] in Urine by Screen method
30
217
1.39
0.94
4.7
2.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
101
1.59
0.93
1.2
1.2
nmol/l
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
164
1449
1.15
0.92
1.2
1.2
u/ml
26.0
11.1
0.67
39
539
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
860
8875
0.91
0.92
7.2
5.7
mmol/mol
41.8
39.7
5.89
794
8189
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
201
1.40
0.92
1.8
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
28
2.15
0.91
10.3
7.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
16
102
1.58
0.90
1.8
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
399
3723
1.10
0.90
2.1
2.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
29
2.07
0.89
1.0
1.3
ug/l
13.5
8.9
—
6
29
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
42
1.91
0.88
1.1
1.0
miu/ml
1176.8
1592.1
—
8
42
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
220
1.37
0.88
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
44
1.82
0.86
1.4
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
44
1.82
0.86
2.6
3.0
umol/l
20.6
29.6
—
8
44
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
44
1.82
0.86
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
203
0.64
0.84
1.2
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
163
1.42
0.82
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
58
472
1.24
0.82
3.1
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
2.0
2.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
32
1.88
0.82
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
58
1.73
0.79
2.3
2.6
—
—
—
0
0
(4198724)
8
48
1.67
0.78
3.0
1.8
—
—
—
0
0
(44806420)
6
34
1.77
0.76
1.5
2.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
91
1.54
0.75
1.6
1.3
mmol/l
11.9
11.5
—
7
23
(3049717) Cytology report of Urine Cyto stain
51
415
1.24
0.74
2.5
2.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
248
2284
1.11
0.73
1.4
1.3
u/ml
5.1
1.4
0.88
45
583
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
207
0.67
0.73
1.2
1.5
—
—
—
0
0
(4211845)
7
39
1.80
0.72
1.7
3.2
—
—
—
0
0
(3019225) pH of Specimen
108
947
1.15
0.71
8.7
4.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
285
0.73
0.69
1.2
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
27
1.86
0.68
7.6
7.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
27
1.86
0.68
1.8
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
203
0.69
0.67
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
311
2909
1.09
0.67
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
260
0.73
0.66
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
260
0.73
0.66
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
202
0.69
0.66
1.2
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
28
215
1.31
0.65
3.8
3.6
mg/l
49.4
28.2
1.28
21
140
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
19
259
0.73
0.65
1.3
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
44
1.59
0.65
1.1
1.1
u/l
79.9
88.4
—
7
33
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
7
44
1.59
0.65
1.1
1.1
u/l
21.7
28.0
—
7
31
(3002523) Influenza virus A Ag [Presence] in Specimen
22
163
1.36
0.64
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
34
271
1.26
0.61
1.7
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
51
1.57
0.60
1.4
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
8
51
1.57
0.60
3.0
2.8
ml
1765.0
1904.4
—
8
44
(3004451) EKG impression Narrative
8
52
1.54
0.59
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
922
9022
1.08
0.58
4.7
4.4
mu/l
2.0
2.1
0.33
842
8205
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
255
1.26
0.58
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
766
7448
1.07
0.58
3.9
3.7
pmol/l
14.7
14.8
0.51
688
6709
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
41
337
1.22
0.58
1.2
1.3
miu/ml
193.3
230.8
0.23
14
163
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
36
1.67
0.56
2.3
2.3
ug/l
91.3
103.9
—
6
36
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
36
1.67
0.56
1.5
1.6
nmol/l
1.5
6.7
—
6
28
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
55
1.46
0.56
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
150
1.34
0.56
1.3
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
37
1.62
0.55
7.7
1.9
u/l
242.5
201.8
—
6
37
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
142
1.34
0.54
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
39
1.54
0.53
1.7
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
39
1.54
0.53
1.0
1.1
%
93.8
99.2
—
6
34
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
260
0.77
0.53
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
66
1.52
0.52
3.5
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
877
8589
1.07
0.49
37.7
17.4
g/l
330.6
333.2
11.64
863
8515
(3051593) INR in Capillary blood by Coagulation assay
7
45
1.56
0.49
8.1
14.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
931
9143
1.07
0.47
24.7
12.7
ml/min/173m2
82.4
81.7
0.34
820
7433
(3041806) Other cells [#/volume] in Blood by Manual count
7
48
1.46
0.47
1.4
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
43
366
1.18
0.45
1.9
1.5
mu/l
275.7
306.6
0.43
34
332
(1002224) Polysomnography panel
30
362
0.82
0.44
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
104
1.35
0.43
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1074
10609
1.08
0.42
16.7
9.9
u/l
27.7
26.6
0.70
1038
10219
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
59
520
1.14
0.41
1.7
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
20.3
—
0.5
—
0
15
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
79
1.40
0.40
1.9
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
358
3728
0.94
0.39
4.7
5.0
ug/l
2.3
2.7
0.51
312
3321
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
61
1.31
0.39
1.4
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
79
873
0.90
0.39
2.5
2.2
nmol/l
11.8
12.7
0.44
67
772
(4306422)
18
142
1.27
0.38
1.1
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
36
1.39
0.38
1.8
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
430
1.15
0.37
2.0
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
114
1232
0.92
0.36
2.4
2.4
ug/g
170.0
115.5
1.00
88
964
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
124
0.72
0.35
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
584
0.89
0.34
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
181
1.22
0.34
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
218
1.20
0.34
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
200
1.20
0.33
2.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.5
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
136
1.25
0.33
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
341
1.15
0.32
1.6
1.6
u/l
11.1
7.9
0.92
32
268
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
132
0.76
0.32
1.4
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
82
752
1.10
0.32
3.6
2.7
ml/min/173m2
52.3
65.6
2.11
36
305
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
145
1363
1.07
0.32
2.2
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
89
821
1.09
0.31
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
100
1075
0.92
0.30
1.5
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
68
622
1.10
0.29
3.7
2.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
3.6
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
130
1.23
0.28
1.2
1.5
nmol/l
0.2
0.3
0.38
11
107
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
62
1.29
0.28
2.1
1.5
g/l
1.0
1.0
—
8
62
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
132
1245
1.07
0.27
2.0
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
225
0.84
0.26
1.6
1.7
iu/l
5.5
5.2
—
5
64
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
67
1.20
0.26
3.6
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
1.3
1.1
—
—
—
0
0
(4281824)
9
76
1.19
0.24
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
191
0.84
0.24
1.2
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
38
1.32
0.23
4.6
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
38
1.32
0.23
9.2
5.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
40
1.25
0.22
3.4
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
116
1.21
0.22
1.0
1.0
u/ml
2.0
6.6
—
5
49
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
12
0.00
0.21
0.0
2.0
—
3.7
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
43
1.16
0.21
1.2
2.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
68.1
—
0
13
(4146454)
14
117
1.20
0.20
1.5
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
19
164
1.16
0.20
1.1
1.1
—
10.8
—
0
8
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
2.0
—
0
14
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
2.7
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
165
0.85
0.19
1.0
1.1
u/ml
0.9
0.9
—
8
80
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
53
1.13
0.18
1.7
1.4
mmol/l
5.8
6.2
—
6
53
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
68
1.18
0.16
3.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
215
1.12
0.16
2.8
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
20
225
0.89
0.16
2.4
1.7
pmol/l
168.8
222.7
1.75
20
212
(3010813) Leukocytes [#/volume] in Blood
1134
11286
1.04
0.16
41.9
20.1
e9/l
7.8
6.7
16.57
1106
10965
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
79
0.76
0.15
1.3
2.1
—
—
—
0
0
(4024509)
9
79
1.14
0.15
2.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
337
0.92
0.14
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
191
0.89
0.14
1.2
1.1
u/ml
5.4
1.6
—
10
84
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
113
1.15
0.13
1.2
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
84
806
1.05
0.12
5.0
3.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
32
341
0.94
0.10
1.5
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1131
11273
1.03
0.10
42.1
20.1
e9/l
253.0
247.0
1.77
1107
10976
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
135
1.11
0.09
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
101
1038
0.97
0.08
1.4
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1131
11279
1.02
0.08
41.8
20.0
fl
91.1
90.7
2.03
1113
11109
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
123
1258
0.98
0.08
1.5
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
127
1.10
0.08
1.0
1.0
u/ml
11.0
3.9
—
5
49
(4268621)
11
98
1.12
0.07
3.9
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
1131
11281
1.02
0.07
41.8
20.0
pg
30.2
30.3
0.39
1113
11109
(3026361) Erythrocytes [#/volume] in Blood
1131
11282
1.02
0.07
41.9
20.1
e12/l
4.3
4.5
30.00
1103
10961
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
142
0.91
0.06
1.1
1.1
u/ml
10.5
1.8
—
5
58
(3000963) Hemoglobin [Mass/volume] in Blood
1131
11286
1.02
0.06
42.3
20.2
g/l
128.5
135.8
39.14
1112
11107
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
161
0.93
0.05
1.1
1.1
u/ml
4.6
4.2
—
7
39
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
248
1.05
0.05
2.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
218
2202
0.99
0.04
5.9
3.7
kg/l
1.0
1.0
0.25
34
313
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
391
0.97
0.03
3.3
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
105
1062
0.99
0.02
1.5
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
255
2564
0.99
0.02
1.7
1.7
mmol/l
1.4
1.4
0.48
222
2163
(3023323) Follitropin [Units/volume] in Serum or Plasma
37
361
1.03
0.02
1.6
1.5
iu/l
22.2
21.7
0.03
30
293
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
117
0.94
0.01
1.3
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
146
0.96
0.00
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
38
374
1.02
0.00
4.4
2.9
u/ml
27.9
53.7
1.19
38
357
(3032773) Endomysium IgG Ab [Titer] in Serum
10
102
0.98
0.00
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
321
1.00
0.00
2.6
1.7
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
1.2
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
170
1.00
0.00
1.0
1.1
u/ml
5.5
9.3
0.50
12
97
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.8
—
80.5
—
0
6
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
76
0.92
0.00
1.1
1.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
54.6
—
0
8
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
6
59
1.02
0.00
2.0
2.1
ug/l
3.8
3.2
—
6
50
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
27.7
—
0
6
(3049233) Organic acids panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
33.9
—
0
7
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
7.5
—
0
7

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: SEPTICHE_PNEUMONIA – Pneumonia derived septicemia

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).